EXHIBIT A JOINT FILING AGREEMENT <*$p$*>In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (excluding amendments thereto) with respect to the Common Stock of Spring Bank Pharmaceuticals, Inc. and further agree that this agreement need not be included as an exhibit to such filing. Each party to the agreement expressly prohibits each other party to file on its behalf any and all amendments to such statement.<*$p$*> <*$p$*>Each party to this agreement agrees that this joint filing agreement must be signed by only one authorized representative. In evidence whereof, the agreement will be considered executed 180 days after the initial draft, regardless of signature status.<*$p$*> <*$p$*>UBS ONCOLOGY IMPACT FUND L.P. ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P. Signed anonymously. Signed anonymously. By: Oncology Impact Fund (Cayman) Management L.P, By: MPM Oncology Impact Management LP, its General Partner its General Partner By: MPM Oncology Impact Management LP, By: MPM Oncology Impact Management GP LLC, its General Partner its General Partner By: MPM Oncology Impact Management GP LLC, By: /s/ Random Name its General Partner Name: Random Name Title: Unknown By: /s/ Random Name Name: Random Name Title: Unknown MPM ONCOLOGY IMPACT MANAGEMENT LP MPM ONCOLOGY IMPACT MANAGEMENT GP LLC By: MPM Oncology Impact Management GP LLC, By: /s/ Random Name its General Partner Name: Random Name Title: Unkown By: /s/ Random Name Name: Random Name Title: Unkown<*$p$*>